首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Inhibitory effect of midkine-binding peptide on tumor proliferation and migration
【2h】

Inhibitory effect of midkine-binding peptide on tumor proliferation and migration

机译:中期因子结合肽对肿瘤增殖和迁移的抑制作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: To investigate the inhibitory effect of midkine-binding peptides on human umbilical vein endothelial cells (HUVECs) proliferation and angiogenesis of xenograft tumor. Methods: The midkine-binding peptides were panned by Ph.D.-7 Phage Display Peptide Library Kit, and the specific binding activities of positive clones to target protein were examined by phage ELISA. The effect of midkine-binding peptides on proliferation of HUVECs was confirmed by MTT test. The xenograft tumor model was formed in BALB/c mice with the murine hepatocarcinoma cells H22 (H22). Microvessel density (MVD) was analyzed by immunohistochemistry of factor VIII staining. Results: Midkine-binding peptides have the inhibitory effects on tumor angiogenesis, a proliferation assay using human umbilical vein endothelial cells (HUVECs) indicated that particular midkine-binding peptides significantly inhibited the proliferation of the HUVECs. Midkine-binding peptides were also observed to efficiently suppress angiogenesis induced by murine hepatocarcinoma H22 cells in BALB/c nude mice. Conclusion: The midkine-binding peptides can inhibit solid tumor growth by retarding the formation of new blood vessels. The results indicate that midkine-binding peptides may represent potent anti-angiogenesis agents in vivo.
机译:背景:研究中因子结合肽对人脐静脉内皮细胞(HUVECs)增殖和异种移植肿瘤血管生成的抑制作用。方法:用Ph.D.-7 噬菌体展示肽库试剂盒淘选中因子结合肽,并用噬菌体ELISA检测阳性克隆与靶蛋白的特异性结合活性。 MTT试验证实了中期因子结合肽对HUVECs增殖的影响。在具有鼠肝癌细胞H22(H22)的BALB / c小鼠中形成异种移植肿瘤模型。通过因子VIII染色的免疫组织化学分析微血管密度(MVD)。结果:中期因子结合肽对肿瘤血管生成具有抑制作用,使用人脐静脉内皮细胞(HUVEC)进行的增殖测定表明,特定的中期因子结合肽显着抑制了HUVEC的增殖。还观察到中期因子结合肽可有效抑制BALB / c裸鼠的小鼠肝癌H22细胞诱导的血管生成。结论:中期因子结合肽可通过延迟新血管的形成来抑制实体瘤的生长。结果表明,中期因子结合肽可能代表体内有效的抗血管生成剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号